<div><p>The epidemiology of chronic viral infections, such as those caused by Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV), is affected by the risk group structure of the infected population. Risk groups are defined by each of their members having acquired infection through a specific behavior. However, risk group definitions say little about the transmission potential of each infected individual. Variation in the number of secondary infections is extremely difficult to estimate for HCV and HIV but crucial in the design of efficient control interventions. Here we describe a novel method that combines epidemiological and population genetic approaches to estimate the variation in transmissibility of rapidly-evolving viral ep...
Genetic analysis of pathogen genomes is a powerful approach to investigating the population dynamics...
Viral infections and their associated diseases represent an eminent and worldwide threat to public h...
Background: Hepatitis C virus (HCV) is estimated to affect 130-180 million people worldwide. Althoug...
The epidemiology of chronic viral infections, such as those caused by Hepatitis C Virus (HCV) and Hu...
International audienceOpioid substitution and syringes exchange programs have drastically reduced he...
Hepatitis C virus (HCV) is a leading worldwide cause of liver disease. Here, we use a new model of H...
Hepatitis C virus (HCV) is a blood-borne RNA virus that infects the liver of its human host. Worldwi...
As the transmission dynamics of HIV change in response to public health action and other external fa...
Viral infections by sexual and droplet transmission routes typically spread through a complex host-t...
Despite major breakthroughs in the treatment of HCV infection in recent years, we have a limited und...
One of the primary objectives of infectious disease research is uncovering the direct\ud link that e...
Background Despite recent breakthroughs in treatment of hepatitis C virus (HCV) infection, we have l...
HIV-1 genetic diversity can be used to infer time since infection (TSI) and infection recency. We ad...
BACKGROUND: Hepatitis C virus (HCV) is estimated to affect 130-180 million people worldwide. Althoug...
International audienceInfection by hepatitis C virus (HCV) leads to one of two outcomes; either the ...
Genetic analysis of pathogen genomes is a powerful approach to investigating the population dynamics...
Viral infections and their associated diseases represent an eminent and worldwide threat to public h...
Background: Hepatitis C virus (HCV) is estimated to affect 130-180 million people worldwide. Althoug...
The epidemiology of chronic viral infections, such as those caused by Hepatitis C Virus (HCV) and Hu...
International audienceOpioid substitution and syringes exchange programs have drastically reduced he...
Hepatitis C virus (HCV) is a leading worldwide cause of liver disease. Here, we use a new model of H...
Hepatitis C virus (HCV) is a blood-borne RNA virus that infects the liver of its human host. Worldwi...
As the transmission dynamics of HIV change in response to public health action and other external fa...
Viral infections by sexual and droplet transmission routes typically spread through a complex host-t...
Despite major breakthroughs in the treatment of HCV infection in recent years, we have a limited und...
One of the primary objectives of infectious disease research is uncovering the direct\ud link that e...
Background Despite recent breakthroughs in treatment of hepatitis C virus (HCV) infection, we have l...
HIV-1 genetic diversity can be used to infer time since infection (TSI) and infection recency. We ad...
BACKGROUND: Hepatitis C virus (HCV) is estimated to affect 130-180 million people worldwide. Althoug...
International audienceInfection by hepatitis C virus (HCV) leads to one of two outcomes; either the ...
Genetic analysis of pathogen genomes is a powerful approach to investigating the population dynamics...
Viral infections and their associated diseases represent an eminent and worldwide threat to public h...
Background: Hepatitis C virus (HCV) is estimated to affect 130-180 million people worldwide. Althoug...